DE60231607D1 - Zusammensetzungen und verfahren zum nachweis von ehrlichia canis- und ehrlichia chaffeensis-antikörpern - Google Patents

Zusammensetzungen und verfahren zum nachweis von ehrlichia canis- und ehrlichia chaffeensis-antikörpern

Info

Publication number
DE60231607D1
DE60231607D1 DE60231607T DE60231607T DE60231607D1 DE 60231607 D1 DE60231607 D1 DE 60231607D1 DE 60231607 T DE60231607 T DE 60231607T DE 60231607 T DE60231607 T DE 60231607T DE 60231607 D1 DE60231607 D1 DE 60231607D1
Authority
DE
Germany
Prior art keywords
ehrlichia
compositions
methods
detecting
canis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60231607T
Other languages
English (en)
Inventor
Robert Lawton
Thomas Patrick O'connor
Barbara Ann Bartol
Paul Scott Machenry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idexx Laboratories Inc
Original Assignee
Idexx Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Laboratories Inc filed Critical Idexx Laboratories Inc
Application granted granted Critical
Publication of DE60231607D1 publication Critical patent/DE60231607D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/29—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Richettsiales (o)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
DE60231607T 2001-01-18 2002-01-16 Zusammensetzungen und verfahren zum nachweis von ehrlichia canis- und ehrlichia chaffeensis-antikörpern Expired - Lifetime DE60231607D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/765,739 US7087372B2 (en) 2001-01-18 2001-01-18 Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
PCT/US2002/001395 WO2002057794A2 (en) 2001-01-18 2002-01-16 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies

Publications (1)

Publication Number Publication Date
DE60231607D1 true DE60231607D1 (de) 2009-04-30

Family

ID=25074352

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60231607T Expired - Lifetime DE60231607D1 (de) 2001-01-18 2002-01-16 Zusammensetzungen und verfahren zum nachweis von ehrlichia canis- und ehrlichia chaffeensis-antikörpern

Country Status (9)

Country Link
US (5) US7087372B2 (de)
EP (2) EP1386167B1 (de)
JP (2) JP4384851B2 (de)
AT (2) ATE426172T1 (de)
AU (1) AU2002251784B2 (de)
CA (1) CA2433394C (de)
DE (1) DE60231607D1 (de)
ES (1) ES2324401T3 (de)
WO (1) WO2002057794A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030129680A1 (en) * 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
US7183060B2 (en) * 2005-02-22 2007-02-27 Idexx Laboratories, Inc. Peptides for detection of antibody to Ehrlichia ewingii
US7087372B2 (en) * 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7407770B2 (en) * 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
EP1879914B1 (de) 2005-04-04 2015-07-15 Idexx Laboratories, Inc. Ehrlichia canis diva (differentiate infected from vaccinated animals) antigenen
BRPI0817202B1 (pt) * 2007-09-21 2018-11-21 Idexx Lab Inc polipeptídeo purificado e método de detecção de anticorpos que se ligam especificamente a um polipeptídio do ehrlichia chaffeensis em uma amostra em teste
MX2010002947A (es) 2007-09-21 2010-08-04 Idexx Lab Inc Metodos y composiciones para deteccion de ehrlichia chaffeensis (p120).
WO2009054957A2 (en) * 2007-10-22 2009-04-30 Cfs Research Llc Methods for diagnosis and treatment of chronic fatigue syndrome
WO2009059170A2 (en) * 2007-10-31 2009-05-07 Idexx Laboratories, Inc. Ehrlichia canis diva (differentiate infection from vaccinated animals)
AU2010321790B2 (en) 2009-11-20 2016-08-04 Zoetis Services Llc Peptides, devices, and methods for the detection of Ehrlichia antibodies
US9651546B2 (en) 2012-10-11 2017-05-16 Abaxis, Inc. Peptides, devices, and methods for the detection of ehrlichia antibodies
US9442112B2 (en) * 2014-04-04 2016-09-13 Abaxis, Inc. Compositions and methods for identifying Ehrlichia species
US20210024879A1 (en) * 2018-04-09 2021-01-28 Kansas State University Research Foundation Biosynthetic activity of the anaplasma phagocytophilum and ehrlichia chaffeensis phagosome in a host cell-free medium
WO2020023950A1 (en) 2018-07-27 2020-01-30 Research Development Foundation Chimeric immunogenic polypeptides
EP3738970A3 (de) * 2019-05-16 2021-02-17 The Trustees of Columbia University in the City of New York Serologischer test zum nachweis der exposition gegenüber und der infektion mit durch zecken übertragene erreger
CN117452342B (zh) * 2023-12-26 2024-03-19 湖南力研光电科技有限公司 一种基于极化特征的箔条干扰检测方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5192679A (en) * 1990-05-03 1993-03-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Growing ehrlichia species in a continuous cell line
US5401656A (en) * 1990-05-03 1995-03-28 United States Of America Use of human immortalized endothelial cells to isolate and propagate Ehrlichia chaffeensis and Ehrlichia canis
DE4100527C2 (de) * 1991-01-10 2001-11-29 Bosch Gmbh Robert Verfahren und Vorrichtung zum Bestimmen von Aussetzern in einer Brennkraftmaschine
AU1970892A (en) * 1991-04-18 1992-11-17 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Identification of a new ehrlichia species from a patient suffering from ehrlichiosis
US5726010A (en) * 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
FR2723950B1 (fr) 1994-08-24 1996-10-25 Bio Merieux Fragments nucleotidiques capables de s'hybrider specifiquemennt a l'adnr ou arnr des rickettsia et leur utilisation comme sondes ou amorces.
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
JPH11503208A (ja) * 1995-04-13 1999-03-23 ジョン メルドラム，ピーター 舗装材用の補完材
US6284238B1 (en) * 1995-06-06 2001-09-04 Aquila Biopharmaceuticals, Inc. Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
US5976860A (en) * 1995-06-06 1999-11-02 Aquila Biopharmaceuticals, Inc. Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
US5955359A (en) * 1995-08-25 1999-09-21 University Of Maryland At Baltimore Method of growing granulocytic ehrlichiae of the Ehrlichia phagocytophila genogroup in promyelocytic leukemia cell culture, and preparing antigens and vaccines of said granulocytic ehrlichiae
US5928879A (en) * 1995-08-25 1999-07-27 The Regents Of The University Of Minnesota Method of diagnosing human granulocytic Ehrlichiosis
US5869335A (en) * 1995-08-25 1999-02-09 Regents Of The University Of Minnesota Method of growing rickettsiae in Ixodes scapularis tick cell culture and preparing antigens and vaccines of rickettsiae
US6015691A (en) * 1996-05-31 2000-01-18 Research Development Foundation Immunodominant 120 kDa surface-exposed adhesion protein genes of Ehrlichia chaffeensis
US6593147B1 (en) * 1996-10-17 2003-07-15 University Of Florida Research Foundation, Inc. Nucleic acid vaccines against rickettsial diseases and methods of use
US6653128B2 (en) 1996-10-17 2003-11-25 University Of Florida Nucleic acid vaccines against rickettsial diseases and methods of use
US6025338A (en) * 1996-10-17 2000-02-15 University Of Florida Nucleic acid vaccines against rickettsial diseases and methods of use
US20020086984A1 (en) 1997-03-21 2002-07-04 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US20020068343A1 (en) 1997-03-21 2002-06-06 Reed Steven G. Compounds and methods for the diagnosis and treatment of ehrlichia infection
US6231869B1 (en) 1997-03-21 2001-05-15 Corixa Corporation Compounds and methods for the diagnosis and treatment of ehrlichia infection
US6207169B1 (en) * 1997-03-21 2001-03-27 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6277381B1 (en) * 1997-03-21 2001-08-21 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
EP0915980B1 (de) * 1997-04-25 2009-08-05 Antigenics Inc. Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung.
US6306394B1 (en) * 1997-04-25 2001-10-23 Aquila Biopharmaceuticals Inc. Nucleic acids, proteins, and methods of use of granulocytic ehrlichia
EP2270032A3 (de) 1997-09-19 2011-01-19 The Ohio State University Research Foundation Äußerer Membran Proteine aus Ehrlichia canis und Ehrlichia chaffeensis
US6544517B1 (en) 1998-09-18 2003-04-08 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US6392023B1 (en) * 1999-03-03 2002-05-21 Research Development Foundation Homologous 28-kilodalton immunodominant protein genes of Ehrlicha canis and uses thereof
US6458942B1 (en) * 1998-11-30 2002-10-01 Research Development Foundation 28-kDa immunoreactive protein gene of Ehrlichia canis and uses thereof
US20020115840A1 (en) 1998-11-30 2002-08-22 Walker David H. Homologous 28-kilodaltion immunodominant protein genes of Ehrlichia canis and uses thereof
US6475492B1 (en) 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
US6355777B1 (en) * 2000-04-28 2002-03-12 Research Development Foundation P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
WO2001083699A2 (en) 2000-05-01 2001-11-08 Research Development Foundation Ehrlichia chaffeensis 28 kda outer membrane protein multigene family
WO2002001395A1 (en) 2000-06-27 2002-01-03 Ubs Ag Method and system for providing distributed functionality and data analysis system utilizing same
US7183060B2 (en) 2005-02-22 2007-02-27 Idexx Laboratories, Inc. Peptides for detection of antibody to Ehrlichia ewingii
US20030129680A1 (en) 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
US7087372B2 (en) 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030194756A1 (en) 2002-04-12 2003-10-16 O'connor Thomas Patrick Peptides for detection of antibody to Ehrlichia equi
US7407770B2 (en) 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
ITRM20010445A1 (it) 2001-07-25 2003-01-27 Sigma Tau Healthscience Spa Alfa-chetoglutarati di principi attivi e composizioni che li contengono.
WO2006138509A2 (en) 2005-06-16 2006-12-28 Research Development Foundation Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis

Also Published As

Publication number Publication date
AU2002251784B2 (en) 2006-09-14
US20020160432A1 (en) 2002-10-31
EP2056112B1 (de) 2012-03-28
ATE551355T1 (de) 2012-04-15
US20070026474A1 (en) 2007-02-01
JP4384851B2 (ja) 2009-12-16
JP2009185037A (ja) 2009-08-20
US7445788B2 (en) 2008-11-04
US20030119082A1 (en) 2003-06-26
WO2002057794A2 (en) 2002-07-25
US7087372B2 (en) 2006-08-08
EP1386167A2 (de) 2004-02-04
CA2433394C (en) 2013-09-10
ATE426172T1 (de) 2009-04-15
CA2433394A1 (en) 2002-07-25
US20070020733A1 (en) 2007-01-25
WO2002057794A3 (en) 2003-11-20
US20020177178A1 (en) 2002-11-28
ES2324401T3 (es) 2009-08-06
JP2005502586A (ja) 2005-01-27
EP2056112A1 (de) 2009-05-06
US7449191B2 (en) 2008-11-11
EP1386167B1 (de) 2009-03-18

Similar Documents

Publication Publication Date Title
ATE426172T1 (de) Zusammensetzungen und verfahren zum nachweis von ehrlichia canis- und ehrlichia chaffeensis- antikírpern
NO20054836L (no) Nogo-reseptorbindingsprotein
ATE554107T1 (de) Als therapeutika geeignete monovalente antikörperfragmente
CY1113224T1 (el) Νεο αντισωμα αντι-ρlgf
ATE489623T1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
DE60334645D1 (de) Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung
CY1117124T1 (el) ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ANTΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
DE60205157D1 (de) Verfahren zum Nachweis von Fluoreszenz in Anwesenheit von Umgebungslicht
DE602006013029D1 (de) Anti-egfr-antikörper
ATE549416T1 (de) Verfahren und zusammensetzungen zum nachweis von autoimmunkrankheiten
DE602005013670D1 (de) Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen
CY1110188T1 (el) Αντισωματα κατα συζυγων φωσφορυλχολινης
ATE494552T1 (de) Docetaxel-immuntest
DK1565489T3 (da) Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet
DK2006301T3 (da) Peptid-baseret immuniseringsterapi til behandling af atherosklerose
DE602005016286D1 (de) Vorrichtung zum frühen und schnellen immunochromatographischen Nachweis von HIV und dessen Anwendung
ATE474226T1 (de) Taxol-immunoassay
EP1832601A3 (de) Zusammensetzungen und Verfahren für den Nachweis von Ehrlichia Canis- und Ehrlichia Chaffeensis-Antikörpern
ATA1242002A (de) Verfahren und einrichtung zum optischen testen von halbleiterbauelementen
DE60130890D1 (de) Induktive Sensoranordnung und Verfahren zur Erfassung von eisernen Objekten
DE50214444D1 (de) Verfahren zum ermitteln von routen und darauf bezogenes navigationssystem
MA28354A1 (fr) Nouvelles combinaisons d'un agent anti-emetique et d'un inhibiteur de l'enkephalinase
ATE498010T1 (de) Natürliche igm-antikörper und inhibitoren davon
ATE529530T1 (de) Rekombinante antikörper zum nachweis und zur neutralisierung von milzbrandtoxin
ATE449177T1 (de) Staphylococcus epidermidis antigene

Legal Events

Date Code Title Description
8364 No opposition during term of opposition